1. Home
  2. ADNT vs FTRE Comparison

ADNT vs FTRE Comparison

Compare ADNT & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adient plc

ADNT

Adient plc

HOLD

Current Price

$24.86

Market Cap

1.6B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$11.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADNT
FTRE
Founded
2016
1996
Country
Ireland
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
ADNT
FTRE
Price
$24.86
$11.00
Analyst Decision
Hold
Buy
Analyst Count
10
10
Target Price
$24.85
$15.50
AVG Volume (30 Days)
1.0M
1.7M
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,439,000,000.00
$2,696,400,000.00
Revenue This Year
$2.76
$3.21
Revenue Next Year
$2.24
$0.25
P/E Ratio
N/A
N/A
Revenue Growth
7.56
N/A
52 Week Low
$10.04
$3.97
52 Week High
$27.32
$18.67

Technical Indicators

Market Signals
Indicator
ADNT
FTRE
Relative Strength Index (RSI) 54.30 32.25
Support Level $25.53 $9.42
Resistance Level $27.32 $11.03
Average True Range (ATR) 1.15 1.31
MACD -0.09 -0.44
Stochastic Oscillator 57.66 19.87

Price Performance

Historical Comparison
ADNT
FTRE

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: